Article Text

Download PDFPDF

Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands

Statistics from Altmetric.com

Hunt B, Malkin SJP, Moes RGJ, et al. Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands. BMJ Open Diabetes Research and Care 2019;7:e000705. doi: 10.1136/bmjdrc-2019-000705.

This article was previously published with an error.

Details of author Bruce Wolffenbuttel have changed. The correct name is Bruce H R Wolffenbuttel and the correct affiliation is University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

View Abstract

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles